cilostazol
- Product NDC
- 70518-2714
- 11-digit product format
- 705182714
- Labeler code
- 70518
- Product ID
- 70518-2714_eb6829d3-46f0-1e76-e053-2995a90ab94a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cilostazol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA077030
- Marketing category
- ANDA
- Marketing start
- 2020-04-29
- Marketing end
- 0000-00-00
- Substance
- CILOSTAZOL
- Active strength
- 100 mg/1
- Pharmacologic classes
- Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2714-0 | 70518271400 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-2714-0) | 90 tablet | 2020-04-29 | 0000-00-00 | No | No | Current |